Close JH: The use of amino acid precursors in nitrogen-accumulation diseases . N Engl J Med290:663-667, 1974
2.
Walser M.: Urea cycle disorders and other hereditary hyperammonemic syndromes. IN The Metabolic Basis of Inherited Disease, 5th ed. Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds). McGraw-Hill, New York , 1982, pp 402-438
3.
Wahren J., Felig P., Hagenfeldt L.: Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest57:987-999, 1976
4.
Elia M., Livesey G.: Branched chain amino acid and oxoacid metabolism in human and rat muscle. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids . Walser M, Williamson JR (eds). Elsevier/ North-Holland, New York, 1981, pp 257-262
5.
Abumrad NN, Rabin D., Wise KL, et al: The disposal of an intravenously administered amino acid load across the human forearm. Metabolism31:463-470, 1982.
6.
Eriksson LS, Hagenfeldt L., Wahren J.: Intravenous infusion of α-oxoisocaproate : influence on amino acid and nitrogen metabolism in patients with liver cirrhosis. Clin Sci62:285-293, 1982
7.
Shinnick FL, Harper AE: Branched-chain amino acid oxidation by isolated rat tissue preparations . Biochim Biophys Acta437 :477-486, 1976
8.
Chang TW, Goldberg AL: The metabolic fates of amino acids and the formation of glutamine in skeletal muscle. J Biol Chem253:3685-3695, 1978
9.
Hagenfeldt L. , Eriksson S., Wahren J.: Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects. Clin Sci59:173-181, 1980
10.
Abumrad NN, Robinson RP, Gooch BR, et al: The effect of leucine infusion on substrate flux across the human forearm. J Surg Res32:453-463, 1982
11.
Walser M., Lund P., Ruderman NB, et al: Synthesis of essential amino acids from their α-keto-analogues by perfused rat liver and muscle. J Clin Invest52:2865-2877, 1973
12.
Pozefsky T. , Walser M.: Effect of intraarterial infusion of the ketoanalogue of leucine on amino acid release by forearm muscle. Metabolism26:807-815, 1977
13.
Mitch WE, Walser M., Sapir DG: Nitrogen sparing induced by leucine compared with that induced by its keto analogue, α-ketoisocaproate, in fasting obese man. J Clin Invest67:553-562, 1981
14.
Sapir DG, Stewart PM, Walser M., et al: Effects of α-ketoisocaproate and of leucine on nitrogen metabolism in post-operative patients. Lancet1:1010-1014, 1983
15.
Abumrad NN, Wise KL, Williams PE, et al: Disposal of α-ketoisocaproate : roles of liver, gut, and kidneys. Am J Physiol243:E123-E131, 1982
16.
Richards P. , Ell S.: Direct evidence for synthesis of valine in man. Lancet1:112-114, 1977
17.
Sapir DG, Walser M.: Nitrogen sparing induced early in starvation by infusion of branched-chain ketoacids. Metabolism26:301-308, 1977
18.
Maddrey WC, Chura C., Coulter AW, et al: Effects of keto-analogues of essential amino acids in portal-systemic encephalopathy. Gastroenterology71:190-195, 1976
19.
Walser M., Sapir DG, Maddrey WC: Use of alpha-keto analogues of essential amino acids. IN Parenteral Nutrition . Fischer J (ed). Little, Brown and Company, Boston, 1976, pp 413-430
20.
Deleted in proof.
21.
Schauder P. , Schroder K., Herbertz L., et al: Metabolism of exogenous and endogenous valine and α-ketoisocaproic acid in patients with liver cirrhosis and in controls: studies in blood and cerebrospinal fluid . JPEN6:343, 1982.
22.
Barbeau A., Bertrand M., Bouchard R., et al: Effect of a valine load test on plasma α-keto acids in Friedreich ataxia. Can J Neurol Sci9:239-242, 1982
23.
Randle PJ, Lau KS, Parker PJ: Regulation of branched-chain 2-oxoacid dehydrogenase complex. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Walser M, Williamson JR (eds). Elsevier/North-Holland, New York, 1981, pp 13-22.
24.
Lau KS, Fatania HR, Randle PJ: Inactivation of rat liver and kidney branched-chain 2-oxoacid dehydrogenase complex by adenosine triphosphatase. FEBS Lett126:66-70, 1981.
25.
Frick GP, Tai L.-R., Blinder L., et al: L-Leucine activates branched chain α-keto acid dehydrogenase in rat adipose tissue. J Biol Chem256:2618-2620, 1981
26.
Meguid MM, Schwarz H., Matthews DE, et al: IN Amino Acids: Metabolism and Medical Applications. Blackburn GL, Grant JP , Young VR (eds.) Wright-PSG, Littleton, MA, 1983, pp 147-154
27.
Sherwin RS: Effect of starvation on the turnover and metabolic response to leucine . J Clin Invest61:1471-1481, 1978
28.
Hambraeus L. , Bilmazes C., Dippel C., et al: Regulatory role of dietary leucine on plasma branched-chain amino acid levels in young men . J Nutr106:230-240, 1976
29.
Eriksson LS , Felig P., Hagenfeldt L., et al: Leucine uptake by splanchnic and leg tissues in man: independence of insulin levels. JPEN6:345, 1982
30.
Buse MG, Reid SS: Leucine: a possible regulator of protein turnover in muscle. J Clin Invest56:1250-1261, 1975
31.
Fulks RM, Li JB, Goldberg AL: Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm . J Biol Chem250:290-298, 1975.
32.
Li JB, Jefferson LS: Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim Biophys Acta544:351-359, 1978
33.
Lundholm K. , Edstrom S., Ekman L., et al: Protein degradation in human skeletal muscle tissue: the effect of insulin, leucine, amino acids and ions. Clin Sci60:319-326, 1981
34.
Buse MG, Atwell R., Mancusi V.: In vitro effect of branched chain amino acids on the ribosomal cycle in muscles of fasted rats. Horm Metab Res11:289-292, 1979
35.
Chua B., Siehl DL, Morgan HE: Effect of leucine and metabolites of branched chain amino acids on protein turnover in heart. J Biol Chem254:8358-8362, 1979
36.
Tischler ME , Desautels M., Goldberg AL: Does leucine, leucyltRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscles?J Biol Chem257:1613-1621, 1982
37.
Tischler ME , Fagan JM: Relationship of the reduction-oxidation state to protein degradation in skeletal and atrial muscle. Arch Biochem Biophys217:191-201, 1982
38.
Seglen PO: Effects of amino acids, ammonia and leupeptin on protein synthesis and degradation in isolated rat hepatocytes. Biochem J174:469-474, 1978.
39.
Kirsch RE, Frith LO'C, Saunders SJ: Stimulation of albumin synthesis by keto analogues of amino acids . Biochim Biophys Acta442:437-441, 1976
40.
Aoki TT, Brennan MF, Fitzpatrick GF, et al.: Leucine meal increases glutamine and total nitrogen release from forearm muscle. J Clin Invest68:1522-1528, 1981
41.
Elia M., Farrell R., Ilic V., et al: The removal of infused leucine after injury, starvation and other conditions in man. Clin Sci59 :275-283, 1980
42.
McNurlan MA , Fern EB, Garlick PJ: Failure of leucine to stimulate protein synthesis in vivo. Biochem J204:831-838, 1982
43.
Walser M., Sapir DG, Mitch WE, et al: Effects of branched chain ketoacids in normal subjects and patients. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids . Walser M, Williamson JR (eds.) Elsevier/ North-Holland, New York, 1981, 291-300
44.
Krebs HA, Lund P.: Aspects of the regulation of the metabolism of branched-chain amino acids . Adv Enzyme Reg15:375-394, 1977
45.
Palaiologos G., Felig P.: Effects of ketone bodies on amino acid metabolism in isolated rat diaphragm. Biochem J154:709-716, 1976
46.
Morgan HE, Chua BH, Boyd TA, et al: Branched chain amino acids and the regulation of protein turnover in heart and skeletal muscle. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Walser M, Williamson JR (eds). Elsevier/ North-Holland, New York, 1981, pp 217-226.
47.
Landaas S.: Inhibition of branched-chain amino acid degradation by ketone bodies . Scand J Clin Lab Invest37:411-418, 1977
48.
Deleted in proof.
49.
Schauder P. , Matthaei D., Henning HV, et al: Blood levels of branched-chain amino acids and α-ketoacids in uremic patients given keto analogues of essential amino acids. Am J Clin Nutr33:1660-1666, 1980
50.
Deleted in proof.
51.
Briggs MH, ed. Urea as a Protein Supplement . Pergamon Press, Oxford, 1967
52.
Mitch WE, Lietman P., Walser M.: Effects of oral neomycin and kanamycin in chronic uremic patients . I. Urea metabolism. Kidney Int11:116-122, 1977
53.
Mitch WE, Walser M.: Effects of oral neomycin and kanamycin in chronic uremic patients. II. Nitrogen balance. Kidney Int11 :123-127, 1977
54.
Heidland A. , Kult J., Rockel A., et al: Evaluation of essential amino acids and keto acids in uremic patients on low protein diet . Am J Clin Nutr31:1784-1792, 1982
55.
Walser M.: Ketoacids in the treatment of uremia. Clin Nephrol3:180-187, 1975
56.
Deleted in proof.
57.
Burns J., Cresswell E., Ell S., et al: Comparison of the effects of keto acid analogues and essential amino acids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets. Am J Clin Nutr31:1767-1775, 1978
58.
Hecking E., Andrzejewski L., Prellwitz W., et al: Double-blind crossover study with oral alpha-ketoacids in patients with chronic renal failure. Am J Clin Nutr33:1678-1681, 1980
59.
Abras E., Walser M.: Nitrogen utilization in uremic patients fed by continuous nasogastric infusion . Kidney Int22:392-397, 1982
60.
Deleted in proof.
61.
Ando A., Orita Y., Nakata K., et al: The effect of essential amino acid supplementation therapy on prognosis of patients with chronic renal failure estimated on the basis of the Markov process. Med J Osaka U32:31-37, 1981
62.
Walser M.: Nutritional support in renal failure: future directions. Lancet1:340-342, 1983
63.
Deleted in proof.
64.
Barsotti G. , Morelli E., Guiducci A., et al: Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron30:310-313, 1982
65.
Fischer JE, Rosen HM, Ebeid AM, et al: The effect of normalization of plasma amino acids on hepatic encephalopathy. Surgery80:77-91, 1976
66.
Marchesini G., Zoli M., Angiolini A., et al: Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism . Hepatology1:294-299, 1981
67.
Muting D., Reikowski J.: Improvement of protein tolerance and hyperammonemia in hepatic encephalopathy by oral treatment with ketoanalogues of essential amino acids (ASA). Zschr Gastroenterol17:587, 1979
68.
Herlong HF, Maddrey WC, Walser M.: The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy. Ann Intern Med93:545-550, 1980
69.
Walker S., Gotz R., Czygan P., et al: Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study. Digestion24:105-111, 1982
70.
Borghi L., Novarini A., Ghinelli F., et al: Preliminary report on nutritional effects of α-ketoacids in chronic hepatic and renal failure. JPEN6:328, 1982
71.
Mendell JR, Griggs RC, Moxley R., et al: A double-blind controlled trial of leucine in Duchenne muscular dystrophy. Ann Neurol12:78, 1982
72.
Stewart PM, Walser M., Drachman DB: Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy. Muscle Nerve5:197-201, 1982
